Current Status of Prostate-Specific Membrane Antigen Targeting in Nuclear Medicine: Clinical Translation of Chelator Containing Prostate-Specific Membrane Antigen Ligands Into Diagnostics and Therapy for Prostate Cancer - Kratochwil, C; Afshar-Oromieh, A; Kopka, K (Semin Nucl Med, 2016)